Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To determine the antiviral efficacy of combination therapy with GS-7977 + ribavirin for 24 weeks in subjects with recurrent HCV post liver transplant as measured by sustained virologic response 12 weeks after discontinuation of therapy (SVR12 defined as HCV RNA < lower limit of quantitation [LLoQ] 12 weeks after last dose of study drug).
Critère d'inclusion
- Recurrent Chronic HCV Post Liver Transplant